Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
There is no effective treatment for autoimmune biliary diseases. Therefore, understanding their immunopathology is crucial. The biliary epithelial cells (BEC), expressing TLR-4, are constantly exposed to gut microbes and bacterial wall LPS, and in settings of inflammation, the immune infiltrate is dense within the peribiliary region of human liver. By dual immunohistochemistry, we affirm human intrahepatic T cell infiltrate includes CCR6+CD4+ and AhR+CD4+ T cells with potential for plasticity to Th17 phenotype. Mechanistically, we demonstrate that Th1 and Th17 inflammatory cytokines and LPS enhance human primary BEC release of the CCR6 ligand CCL20 and BEC secretion of Th17-polarizing cytokines IL-6 and IL-1β. Cell culture assays with human BEC secretome showed that secretome polarizes CD4 T cells toward a Th17 phenotype and supports the survival of Th17 cells. BEC secretome did not promote Th1 cell generation. Additionally, we give evidence for a mutually beneficial feedback of the type 17 cell infiltrate on BEC, showing that treatment with type 17 cytokines increases BEC proliferation, as monitored by Ki67 and activation of JAK2-STAT3 signaling. This study identifies human BEC as active players in determining the nature of the intrahepatic immune microenvironment. In settings of inflammation and/or infection, biliary epithelium establishes a prominent peribiliary type 17 infiltrate via recruitment and retention and enhances polarization of intrahepatic CD4 cells toward Th17 cells via type 17 cytokines, and, reciprocally, Th17 cells promote BEC proliferation for biliary regeneration. Altogether, we provide new insight into cross-talk between Th17 lymphocytes and human primary biliary epithelium in biliary regenerative pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however, this study further suggests a direct role of BECs in driving this disease-promoting, local recruitment and polarization of Th17 cells [195].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [195]
In the citing paper
“Moreover, in vitro LPS stimulation of human BECs leads to the release of T-cell chemokines such as CCL20 and Th17-polarizing cytokines, including IL-1β and IL-6 [195].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [195]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 927
Cited by
The Immunological Basis of Liver Allograft Rejection
Ronca, V., Wootton, G., Milani, C., & Cain, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02155 · Cited by 160
“Subsequent work has shown the active role of BEC in maintaining Th17 dominant differentiation via release of IL-6 and IL-1β, and the stimulation of BEC proliferation by Th17 cytokines (53).”
Background(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Trivedi, P. J., Hirschfield, G. M., Adams, D., & Vierling, J. M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.049 · Cited by 112
Self-citationThe aryl hydrocarbon receptor in liver inflammation
Carambia, A., & Schuran, F. A. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00867-8 · Cited by 83
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease
Horst, A. K., Kumashie, K. G., Neumann, K., Diehl, L., & Tiegs, G. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00568-6 · Cited by 70
Richardson, N., Wootton, G. E., Bozward, A. G., & Oo, Y. H. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00940-w · Cited by 63
Self-citationTerry, L. V., & Oo, Y. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565518 · Cited by 56
Self-citationImmune system and cholangiocytes: A puzzling affair in primary biliary cholangitis
Ronca, V., Mancuso, C., Milani, C., Carbone, M., Oo, Y. H., & Invernizzi, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0320-200r · Cited by 46
Self-citationThe Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis
Barron‐Millar, B., Ogle, L., Mells, G., Flack, S., Badrock, J., Sandford, R., Kirby, J., Palmer, J., Jopson, L., Brain, J., et al. (2021) · Hepatology · doi:10.1002/hep.32011 · Cited by 45
Central role for cholangiocyte pathobiology in cholestatic liver diseases
Jalan-Sakrikar, N., Guicciardi, M. E., O’Hara, S. P., Azad, A., LaRusso, N. F., Gores, G. J., & Huebert, R. C. (2025) · Hepatology · doi:10.1097/hep.0000000000001093 · Cited by 38
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
Bozward, A. G., Ronca, V., Osei‐Bordom, D., & Oo, Y. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711217 · Cited by 40
Self-citationBeyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
Nirmala, S. S., Kayani, K., Gliwiński, M., Hu, Y., Iwaszkiewicz‐Grześ, D., Piotrowska, M., Sakowska, J., Tomaszewicz, M., Morales, J. M. M., Lakshmi, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321228 · Cited by 45
Self-citationExpression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells
Davies, S. P., Ronca, V., Wootton, G. E., Krajewska, N. M., Bozward, A. G., Fiancette, R., Patten, D. A., Yankouskaya, K., Reynolds, G. M., Pat, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44910-2 · Cited by 25
Self-citationThe hepatic microenvironment and regulatory T cells
Osei‐Bordom, D., Bozward, A. G., & Oo, Y. H. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104195 · Cited by 24
Self-citationInflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis
Müller, A.-L., Casar, C., Preti, M., Krzikalla, D., Gottwick, C., Averhoff, P., Rosenstiel, P. C., Gelderblom, M., Altfeld, M. A., Lohse, A. W., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.025 · Cited by 22
Immunobiology of the biliary tract system
Björkström, N. K. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.018 · Cited by 28
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects
Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A. (2025) · Hepatology · doi:10.1097/hep.0000000000001225 · Cited by 22
Self-citationTh17 cells in the liver: balancing autoimmunity and pathogen defense
Taniki, N., Nakamoto, N., Chu, P., Ichikawa, M., Teratani, T., & Kanai∥, T. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00917-9 · Cited by 24
Jiang, T., Zhang, H., Wen, Y., Yin, Y.-S., Yang, K., Yang, J., Lan, T., Tang, C., Yu, J., Tai, W., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107820 · Cited by 23
Fousekis, F. S., Mpakogiannis, K. C., Lianos, G. D., Antonelli, E., Bassotti, G., & Katsanos, K. H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217817 · Cited by 23
Cell-matrix interactions control biliary organoid polarity, architecture, and differentiation
Fiorotto, R., Mariotti, V., Taleb, S. A., Zehra, S. A., Nguyen, M. T., Amenduni, M., & Strazzabosco, M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000094 · Cited by 17
Cellular interactions in self-directed immune-mediated liver diseases
Bozward, A. G., Davies, S. P., Morris, S. M., Kayani, K., & Oo, Y. H. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.01.002 · Cited by 17
Self-citationJiang, X., Otterdal, K., Chung, B. K., Maucourant, C., Rønneberg, J. D., Zimmer, C. L., Øgaard, J., Boichuk, Y., Holm, S., Geanon, D., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.11.283 · Cited by 15
Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again
Liaskou, E., Quraishi, M. N., & Trivedi, P. J. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000809 · Cited by 15
Chen, W., Chen, X., Gao, F., Yao, Q., Cheng, S., Pan, Q., Yu, J., Yang, J., Ma, G., Gong, J., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03617-2 · Cited by 14
Nguyen, H. P. A., Ren, J., Butler, M., Li, H., Qazi, S. H., Sadiq, K., Dao, H. T., & Holterman, A. (2022) · Pediatric Surgery International · doi:10.1007/s00383-022-05115-0 · Cited by 6
Li, L., Peng, H., Li, Z., Zhou, F., & Yu, Q. (2024) · CytoJournal · doi:10.25259/cytojournal_193_2024 · Cited by 3
A novel off-liver sinusoidal progenitor cells in supporting transplantable bioliver engineering
Lai, J., Hu, D., Yan, M., Chen, Q., Shi, H., Yang, Q., Ding, M., Li, L., Zhang, H., & Bai, L. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214358 · Cited by 2
Breakdown in hepatic tolerance and its relation to autoimmune liver diseases
Bozward, A. G., Cè, M., Dell’Oro, L., Oo, Y. H., & Ronca, V. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02853-1 · Cited by 2
Self-citationElzubeir, A., Patel, M., & Rushbrook, S. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104095 · Cited by 3
Use of immunosuppression in non-transplant hepatology
Ronca, V., Bozward, A. G., & Oo, Y. H. (2021) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101760 · Cited by 2
Self-citationImmunology of Autoimmune Liver Diseases
Kayani, K., Bozward, A. G., Davies, S. P., Jeyaraj, R., Asif, A., & Oo, Y. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00173-3
Self-citationIntrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis
Brynjulfsen, L. R. V., ElAbd, H., Øgaard, J., Jördens, M. S., Bozward, A. G., Kearns, D., Jiang, X., Folseraas, T., Trivedi, P. J., Oo, Y. H., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101857 · Cited by 2
Self-citationOrchestrated cell death pathways in cholangiopathies
Guicciardi, M. E., Pistorio, V., Soret, P., Steunou, V., Gores, G. J., & Gautheron, J. (2026) · Gut · doi:10.1136/gutjnl-2026-339264
Bohang, Z., Xiong, Q., He, C., Sun, L., Wang, Y., Zhang, S., Xin, J., Liu, X., Cheng, J., & Song, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1888071
Metadata
- Authors
- Jeffery, H. C., Hunter, S., Humphreys, E. H., Bhogal, R., Wawman, R. E., Birtwistle, J., Atif, M., Bagnal, C. J., Rodriguez Blanco, G., Richardson, N., Warner, S., Dunn, W. B., Afford, S. C., Adams, D. H., & Oo, Y. H.
- Affiliations
- National Institute for Health and Care Research (GB)
- University of Birmingham (GB)
- Human Biomaterial Resource Centre, University of Birmingham , Birmingham B15 2TT ,
- Phenome Centre Birmingham, School of Biosciences, University of Birmingham , Birmingham, Edgbaston B15 2TT ,
- National Health Service (GB)
- Corresponding author
- Hunter, Stuart
- Bhogal, Ricky
- Atif, Muhammad
- Richardson, Naomi
- Warner, Suz
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-09-01
- Volume
- 203
- Issue
- 5
- Pages
- 1151-1159
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC6697739
- OpenAlex
- W2966306915
- Cited by
- 35
- References
- 52
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 5
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- University Hospitals Birmingham NHS Foundation Trust
- National Institute for Health and Care Research (NF-SI-0512-10080, NF-SI-0616-10012)
- University of Birmingham
- Medical Research Council (MR/M009157/1, MC_PC_14123)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- biliary epithelium, Th17 cells, CCL20, CCR6, interleukin-6, IL-1β, TLR4, lipopolysaccharide, JAK2/STAT3 signaling, biliary regeneration, Th17 plasticity, AHR, gut-liver axis
- MeSH terms
- Bile Ducts, Cell Communication, Cells, Cultured, Epithelial Cells, Humans, Lipopolysaccharides, Liver Diseases, Receptors, Aryl Hydrocarbon, Interleukin-17, Cell Proliferation, Receptors, CCR6, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.